PINP商业检测方法的一致化:前进之路
国际临床化学与实验室医学联盟和國際骨质疏松基金会骨代谢联合委员会认为PINP检测一致化是可实现且实际的目标。多中心研究比较了血清和血浆PINP商业检测方法,发现两种自动化方法(Roche Cobas和IDS iSYS)结果相似,但与Orion放射免疫分析法存在显著比例偏倚。在肾功能正常受试者中,两种自动化检测的PINP结果可互换使用,并可应用相似的参考区间和治疗目标。
要点
- Roche Cobas和IDS iSYS两种自动化PINP检测在eGFR>30 mL/min/1.73m2时结果相似,可互换使用。
- Orion RIA与两种自动化PINP检测之间存在显著偏倚。
- 使用通用校准品和开发参考方法有望实现自动化检测与RIA的一致化。
核心结论
- 在肾功能正常(eGFR>30 mL/min/1.73m2)的受试者中,Roche Cobas和IDS iSYS两种自动化PINP检测结果相似,可互换使用,并可应用相似的参考区间和治疗目标。
- Orion RIA与两种自动化检测之间存在显著偏倚,但通过使用通用校准品和开发PINP参考方法,有望实现一致化。
研究设计与样本
- 多中心研究,比较血清和血浆中PINP的商业检测方法,包括Roche Cobas、IDS iSYS自动化方法和Orion放射免疫分析法。
主要发现
- 两种自动化方法(Roche Cobas和IDS iSYS)给出相似结果。
- 两种自动化方法与Orion RIA之间观察到显著的比例偏倚。
- 其他已发表比较这三种检测方法PINP值的研究结果广泛支持本研究发现。
关键数值与推荐
- 两种自动化检测的一致化在eGFR>30 mL/min/1.73m2时成立。
- Orion RIA与两种自动化检测之间存在显著偏倚。
临床怎么用
- 在肾功能正常受试者中,Roche Cobas和IDS iSYS检测的PINP结果可互换使用,并可应用相似的参考区间和治疗目标。
- 临床解读PINP结果时需注意检测方法,Orion RIA与自动化方法之间不可直接互换。
局限性
- 原文未明确报告研究的具体样本量、受试者特征及偏倚的具体数值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: International Federation of Clinical Chemistry and Laboratory Medicine and The International Osteoporosis Foundation Joint Committee on Bone Metabolism believes that the harmonization of PINP assays is an achievable and practical goal. INTRODUCTION: In order to examine the agreement between current commercial assays, a multi-center study was performed for PINP in serum and plasma. METHODS: The automated methods for PINP (Roche Cobas and IDS iSYS) gave similar results. A significant proportional bias was observed between the two automated assays and the Orion radioimmunoassay (RIA) for PINP. RESULTS: Results from other published studies comparing PINP values among these three assays broadly support our findings. Taken together, these results confirm that harmonized PINP measurements exist between the two automated assays (Roche Cobas and IDS iSYS) when the eGFR is > 30 mL/min/1.73m2, but a significant bias exists between the Orion RIA and the two automated assays. CONCLUSION: Therefore, in subjects with normal renal function, PINP results reported by the Roche Cobas and IDS iSYS assays are similar and may be used interchangeably, and similar reference intervals and treatment targets could be applied for the two automated assays. Harmonization between the automated assays and the RIA is potentially possible with the use of common calibrators and the development of a reference method for PINP. This should also help ensure that any new commercial assay developed in the future will attain similar results. IOF and IFCC are committed to working together towards this goal with the cooperation of the reagent manufacturing industry.
引用
- Vasikaran SD, Bhattoa HP, Eastell R, et al. Harmonization of commercial assays for PINP; the way forward. Osteoporos Int. 2020. PMID: 31975180. doi:10.1007/s00198-020-05310-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。